Cargando…
Immune checkpoint inhibitors: use them early, combined and instead of TACE?
Autor principal: | De Toni, Enrico N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497578/ https://www.ncbi.nlm.nih.gov/pubmed/31611301 http://dx.doi.org/10.1136/gutjnl-2019-319658 |
Ejemplares similares
-
Y(90)-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers
por: Rivoltini, Licia, et al.
Publicado: (2023) -
Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor?
por: Bahçecíoğlu, Ömer Faruk, et al.
Publicado: (2021) -
Proton pump inhibitor use associated with changes in gut microbiota composition
por: Reveles, Kelly R, et al.
Publicado: (2018) -
Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer
por: Sundkvist, Anneli, et al.
Publicado: (2019) -
Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis
por: Beeldman, Emma, et al.
Publicado: (2020)